We are scaling up the microalgae cultivation and applying its products in a variety of field including nutritional, feedstock, cosmetics, and fuel.
There are already lots of microalgae biofuel companies in the world, and none of them made a big fortune now. People tends to use transgenic strain to change its cellular component and aim for higher productivity, however, most of strains can not be cultivated in large scale under cost-effective way.
We have a dedicated team in China focusing on commercial scale cultivation of microalgae strain and development of a unique heterotrophy-autotrophy route to mass culture microalgae in a short period of time with a significantly reduction of carbon footprint. Backed by Shenzhen Qianhai Xiaozao Technology Co., Ltd (SQXT), Lyxia is delivering the World’s First EPA-rich oil from microalgae in the commercial scale, instead of fish source.
Currently our main product in the market is EPA-rich oil derived from microalgae. We provide EPA-rich oil with various concentration which we extract, recover and purify from the microalgae. The essential part of the ingredients are EPA, eicosapentaenoic acid, an omega-3 fatty acid. In chemical structure, EPA is a carboxylic acid with a 20-carbon chain and five cis double bonds; the first double bond is located at the third carbon from the omega end. 
EPA is a polyunsaturated fatty acid (PUFA) that acts as a precursor for prostaglandin-3 (which inhibits platelet aggregation), thromboxane-3, and leukotriene-5 eicosanoids. EPA is used in combination with docosahexaenoic acid (DHA) in fish oil preparations for a variety of conditions, including preventing and reversing heart disease, and decreasing irregular heartbeats; as well as asthma, cancer, menstrual problems, hot flashes, hay fever, lung diseases, lupus erythematosus, and kidney disease. EPA and DHA are also used in combination for migraine headache prevention in adolescents, skin infections, Behçet’s syndrome, high cholesterol, high blood pressure, psoriasis, Raynaud’s syndrome, rheumatoid arthritis, Crohn’s disease, and ulcerative colitis. 
EPA is also used in combination with RNA and L-arginine after surgery to reduce infections, improve wound healing, and shorten recovery time.